CD4 and hepatocellular carcinoma: Our research revealed that PHLDA2 exhibited the capacity to augment the infiltration of diverse immune cells in HCC, encompassing Tregs, macrophages, dendritic cells, T cells CD4+, T cells CD8+, B cells, and NK cells.